Teva Historical Income Statement
TEVA Stock | USD 13.98 0.07 0.50% |
Historical analysis of Teva Pharma income statement accounts such as Other Operating Expenses of 7.6 B, Operating Income of 732.2 M, EBIT of 411.4 M or Ebitda of 411.4 M can show how well Teva Pharma Industries performed in making a profits. Evaluating Teva Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Teva Pharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Teva Pharma Industries latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Teva Pharma Industries is a good buy for the upcoming year.
Teva |
About Teva Income Statement Analysis
Teva Pharma Industries Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Teva Pharma shareholders. The income statement also shows Teva investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Teva Pharma Income Statement Chart
Teva Pharma Industries Income Statement is one of the three primary financial statements used for reporting Teva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Teva Pharma Industries revenue and expense. Teva Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Teva Pharma's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 732.2 M, whereas Depreciation And Amortization is forecasted to decline to about 667.3 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Teva Pharma Industries generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Teva Pharma Industries minus its cost of goods sold. It is profit before Teva Pharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Teva Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Teva Pharma Industries current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At present, Teva Pharma's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 732.2 M, whereas Depreciation And Amortization is forecasted to decline to about 667.3 M.
2021 | 2023 | 2024 (projected) | Interest Expense | 1.1B | 1.0B | 1.1B | Depreciation And Amortization | 1.3B | 1.2B | 667.3M |
Teva Pharma income statement Correlations
Click cells to compare fundamentals
Teva Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teva Pharma income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 1.8B | 416M | 1.6B | 1.3B | 1.2B | 667.3M | |
Interest Expense | 822M | 963M | 1.1B | 966M | 1.0B | 1.1B | |
Total Revenue | 16.9B | 16.7B | 15.9B | 14.9B | 15.8B | 9.5B | |
Gross Profit | 7.5B | 7.7B | 7.6B | 7.0B | 7.6B | 4.8B | |
Other Operating Expenses | 14.2B | 13.6B | 12.8B | 12.2B | 12.7B | 7.6B | |
Operating Income | (1.6B) | 2.8B | 3.1B | 3.2B | 433M | 732.2M | |
Ebit | 1.3B | 2.8B | 3.1B | 3.2B | 433M | 411.4M | |
Ebitda | 3.2B | 4.6B | 4.5B | 4.1B | 433M | 411.4M | |
Cost Of Revenue | 9.4B | 8.9B | 8.3B | 8.0B | 8.2B | 4.7B | |
Total Operating Expenses | 4.8B | 4.7B | 4.5B | 4.3B | 4.5B | 2.9B | |
Income Before Tax | (1.3B) | (4.4B) | 658M | (3.1B) | (624M) | (592.8M) | |
Total Other Income Expense Net | (4.1B) | (7.5B) | (2.5B) | (5.9B) | (1.1B) | (1.1B) | |
Net Income | (999M) | (4.0B) | 417M | (2.4B) | (559M) | (531.1M) | |
Income Tax Expense | (278M) | (168M) | 211M | (638M) | (65M) | (61.8M) | |
Research Development | 1.0B | 997M | 967M | 838M | 953M | 809.2M | |
Selling General Administrative | 1.2B | 1.2B | 1.1B | 1.2B | 1.2B | 1.2B | |
Net Income Applicable To Common Shares | (999M) | (4.0B) | 417M | (2.4B) | (2.1B) | (2.0B) | |
Minority Interest | (2M) | (109M) | 39M | 53M | 56M | 74.7M | |
Selling And Marketing Expenses | 2.6B | 2.5B | 2.4B | 2.3B | 2.3B | 3.2B | |
Net Income From Continuing Ops | (987M) | (4.2B) | 447M | (2.4B) | (615M) | (645.8M) | |
Tax Provision | (278M) | (168M) | 211M | (638M) | (7M) | (7.4M) | |
Net Interest Income | (877M) | (963M) | (962M) | (966M) | (1.1B) | (1.1B) | |
Reconciled Depreciation | 1.7B | 1.6B | 1.3B | 1.3B | 1.2B | 1.3B | |
Non Operating Income Net Other | (1.0B) | (835M) | (696M) | (1.0B) | (1.2B) | (1.3B) |
Teva Pharma Investors Sentiment
The influence of Teva Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Teva. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Teva Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Teva Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Teva Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Teva Pharma.
Teva Pharma Implied Volatility | 68.36 |
Teva Pharma's implied volatility exposes the market's sentiment of Teva Pharma Industries stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Teva Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Teva Pharma stock will not fluctuate a lot when Teva Pharma's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Teva Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Teva Pharma's short interest history, or implied volatility extrapolated from Teva Pharma options trading.
Currently Active Assets on Macroaxis
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Teva Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.50) | Revenue Per Share 14.161 | Quarterly Revenue Growth 0.148 | Return On Assets 0.0454 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.